English
Home > Products > CAS NO 2382664-60-8

China CAS NO 2382664-60-8 Factory

Our crew through skilled training. Skilled skilled knowledge, strong sense of company, to meet the company wants of customers for CAS NO 2382664-60-8,2382664-60-8,Pemigatinib intermediate,Pemigatinib advance intermediate,1H-Pyrrolo[2,3-b]pyridine-5-carboxaldehyde, Created merchandise with brand price. We attend seriously to produce and behave with integrity, and via the favor of buyers at your house and overseas inside the xxx industry.
CAS NO 2382664-60-8, To get more information about us as well as see all our products and solutions, you should visit our website. To get more information please feel free to let us know. Thank you very much and wish your business always be great!

Related Products

Hot Products

  • Capmatinib hydrochloride

    Capmatinib hydrochloride

    Product Name:Capmatinib hydrochloride
    Molecular Formula:C23H20ClFN6O2
    Molecular Weight;466.9
    CAS Registry Number;1865733-40-9
  • Levetiracetam

    Levetiracetam

    Product Name:Levetiracetam
    Molecular Formula:C8H14N2O2
    Molecular Weight:170.20896
    CAS Registry Number:102767-28-2
  • Sildenafil citrate

    Sildenafil citrate

    Product Name:Sildenafil citrate
    Molecular Formula:C28H38N6O11S
    Molecular Weight;666.7
    CAS Registry Number;171599-83-0
  • Vitamin D3

    Vitamin D3

    Product Name:Vitamin D3
    Molecular Formula:C27H44O
    Molecular Weight:384.64
    CAS Registry Number:67-97-0
  • (R)-3-Methyl-1-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)butan-1-aMine hydrochloride

    (R)-3-Methyl-1-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)butan-1-aMine hydrochloride

    Product Name:(R)-3-Methyl-1-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)butan-1-aMine hydrochloride
    Molecular Formula:C11H25BClNO2
    Molecular Weight:249.59
    CAS Registry Number:1243174-57-3
  • 1,2,4-Trifluorobenzene

    1,2,4-Trifluorobenzene

    Product Name:1,2,4-Trifluorobenzene
    Molecular Formula:C6H3F3
    Molecular Weight:132.08
    CAS Registry Number:367-23-7
  • Related Blog
  • Reviews

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products can be produced in ordinary chemical plants without obtaining a pharmaceutical production license. As long as the technical indicators meet certain level requirements, they can be used to participate in the synthesis and production of drugs.

  • CAS 148553-50-8 What is Pregabalin?

    Pregabalin is an anti-epileptic drug, also called an anticonvulsant. It works by slowing down impulses within the brain that cause seizures. Pregabalin also affects chemicals within the brain that send pain signals across the systema nervosum.

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept